Assignee
ZEVRA DENMARK AS
DK·2 granted patents·7 pending applications·1 citations·filing 2021–2025
Top patents by PatentIndex Score
9 records- 0187US11938125B2Use of Hsp70 as a regulator of enzymatic activityZEVRA DENMARK AS·Filed 2022·Granted Mar 26, 2024·1 cites·5 claims
- 0284US12576076B2Use of HSP70 as a regulator of enzymatic activityZEVRA DENMARK AS·Filed 2024·Granted Mar 17, 2026·0 cites·9 claims
- 0371US2025387384A1Arimoclomol for treating glucocerebrosidase associated disordersZEVRA DENMARK AS·Filed 2025·Application pending·0 cites
- 0466US2024024306A1Processes for preparing arimoclomol citrate and intermediates thereofZEVRA DENMARK AS·Filed 2023·Application pending·0 cites
- 0560US2023416224A1Processes for preparing arimoclomol citrate and intermediates thereofZEVRA DENMARK AS·Filed 2021·Application pending·0 cites
- 0652US2024390383A1Dioxazines and their use in treatment of gba-related diseasesZEVRA DENMARK AS·Filed 2022·Application pending·0 cites
- 0752US2024390357A1Pyridines and their use in treatment of gba-related diseasesZEVRA DENMARK AS·Filed 2022·Application pending·0 cites
- 0852US2024383853A1Oximes and their use in treatment of gba-related diseasesZEVRA DENMARK AS·Filed 2022·Application pending·0 cites
- 0945US2024115558A1Arimoclomol for the treatment of niemann pick disease, type c, in patients with er type missense mutationsZEVRA DENMARK AS·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →